Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-26T01:48:24.064Z Has data issue: false hasContentIssue false

CBD and the neural correlates of anxiety

Published online by Cambridge University Press:  16 April 2020

P. Fusar-Poli
Affiliation:
Neuroimaging Section, Department of Psychological Medicine, Institute of Psychiatry, King's College, London, United Kingdom
S. Bhattacharyya
Affiliation:
Neuroimaging Section, Department of Psychological Medicine, Institute of Psychiatry, King's College, London, United Kingdom
S. Borgwardt
Affiliation:
Neuroimaging Section, Department of Psychological Medicine, Institute of Psychiatry, King's College, London, United Kingdom
K. Rubia
Affiliation:
Neuroimaging Section, Department of Psychological Medicine, Institute of Psychiatry, King's College, London, United Kingdom
C. O'Carroll
Affiliation:
Neuroimaging Section, Department of Psychological Medicine, Institute of Psychiatry, King's College, London, United Kingdom
M. Seal
Affiliation:
Neuroimaging Section, Department of Psychological Medicine, Institute of Psychiatry, King's College, London, United Kingdom
R. Martin-Santos
Affiliation:
Neuroimaging Section, Department of Psychological Medicine, Institute of Psychiatry, King's College, London, United Kingdom
J. Crippa
Affiliation:
Department of Neurology, Psychiatry and Medical Psycology, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil
Z. Atakan
Affiliation:
National Psychosis Unit, South London and Maudsley NHS Trust, London, United Kingdom
P. McGuire
Affiliation:
Neuroimaging Section, Department of Psychological Medicine, Institute of Psychiatry, King's College, London, United Kingdom

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims

The study sought to examine the neurophysiological effects of cannabidiol (CBD) on the emotional processing using functional Magnetic Resonance Imaging (fMRI).

Method

Fifteen healthy male participants (age range 18-35) with a lifetime exposure to cannabis of 15 times or less were recruited in a double blind event-related fMRI design. Prior to each scanning session, participants were given an oral dose of either 600mg CBD or a placebo. The blood levels of drugs were monitored via an intravenous line, while systolic and diastolic blood pressure and heart rate (beats per minute) were recorded manually. During the scan, subjects were presented with 10 different facial identities, each identity expressing 50% or 100% intensities of fear or a neutral expression. Neuropsychological performance and symptoms ratings were recorded at baseline, immediately before scanning (1 hr), immediately after scanning (2 hr), and one hour post scanning (3 hr).

Results

CBD had no significant effect on the gender discrimination task. Reaction times were significantly faster when processing 100% fearful faces than compared to 50% fearful and neutral faces. CBD had a significant effect on brain activation in response to faces with emotional expressions, decreasing activation in the right posterior cingulate gyrus and in the right cerebellum, when compared to placebo. Furthermore, a significant interaction effect was observed. In the right cingulate gyrus CBD attenuated activation during the processing of intense fearful faces but had no effect of neural response to neutral or mild fearful faces.

Conclusion

CBD significantly modulates the neurophysiological response associated with anxiety.

Type
S14. Symposium: Neurocognitive and Clinical Effects of Cannabinoids
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.